Tag Archives: gilles tapolsky

Advanced Cancer Therapeutics awarded Phase I SBIR grant

Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, announced today that it has been awarded a Phase I Small Business Innovative Research (SBIR) grant in the amount of $158,000 by the National Cancer Institute of the National Institutes of Health (NIH) to support the development of a

Top